Share
))
HBO and The Ringer's Bill Simmons hosts the most downloaded sports podcast of all time, with a rotating crew of celebrities, athletes, and media staples, as well as mainstays like Cousin Sal, Joe House, and a slew of other friends and family members who always happen to be suspiciously available.
…
continue reading
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on October 16, 2024 18:09 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 421233979 series 3450262
Content provided by Roots to Risk Podcast With Eric Schneider & Isaac Bock, Roots to Risk Podcast With Eric Schneider, and Isaac Bock. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Roots to Risk Podcast With Eric Schneider & Isaac Bock, Roots to Risk Podcast With Eric Schneider, and Isaac Bock or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Dive into the fascinating world of minor cannabinoids with the Roots to Risk Podcast. Hosts Eric Schneider and Isaac Bock are joined by Dr. Shane Johnson from Bay Medica, a leading figure in the cannabis and cannabinoid space. Dr. Johnson shares insights into the biotech side of the industry, focusing on the development of rare cannabinoids and their potential applications in healthcare and consumer products.
Learn about the groundbreaking work being done at Bay Medica, where a team of experts is using a biotechnology approach to produce pure, plant-identical cannabinoids. Discover the unique effects of cannabinoids like THCV, CBC, and CBT, and how small structural differences can lead to significant variations in their effects.
Explore the future of cannabinoid-based medicine, from FDA-approved drugs to potential treatments for neurodegenerative disorders and cancer. Dr. Johnson discusses the importance of consumer education, quality control, and regulatory reform in advancing the industry and ensuring safe, effective products for all.
Tune in to the Roots to Risk Podcast for an enlightening conversation on the science, business, and potential of minor cannabinoids in the cannabis industry.
52 episodes
